Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

3.8%

5 terminated/withdrawn out of 133 trials

Success Rate

90.9%

+4.4% vs industry average

Late-Stage Pipeline

12%

16 trials in Phase 3/4

Results Transparency

0 of 50 completed trials have results

Key Signals

23 recruiting

Enrollment Performance

Analytics

N/A

59(72.8%)

Phase 3

10(12.3%)

Phase 4

6(7.4%)

Phase 2

4(4.9%)

Phase 1

2(2.5%)

81Total

N/A(59)

Phase 3(10)

Phase 4(6)

Phase 2(4)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (133)

Showing 20 of 133 trials

NCT06629896Not ApplicableRecruiting

Contrast Enhancement Mammography vs MRI for the Surveillance of Women at High Risk of Breast Cancer: Con-trust Randomized Controlled Trial

Role: collaborator

NCT06716502Not ApplicableRecruiting

A New Portable Device for Non-invasive Ventilatory Support

Role: collaborator

NCT05750706Completed

Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative

Role: collaborator

NCT06652776Enrolling By Invitation

The Italian Registry of Patients With Chronic Obstructive Pulmonary Disease

Role: collaborator

NCT07544290Enrolling By Invitation

Autoimmune Hyperthyroidism in Prepubertal Children

Role: collaborator

NCT07505563Not ApplicableCompleted

MiniFlo for Advanced Dupuytren's Disease

Role: lead

NCT07471100Not ApplicableNot Yet Recruiting

Neuromodulation-Induced Cortical Prehabilitation in High Grade Glioma Near the Motor Pathway: Cortical Plasticity Assessed by Navigated Transcranial Magnetic Stimulation (nTMS)

Role: collaborator

NCT05799690Not ApplicableActive Not Recruiting

Comparison of Different Rehabilitation Protocols in Parkinson's Disease With Postural Instability and Gait Disorders

Role: collaborator

NCT07393919Phase 4Not Yet Recruiting

Discontination of Antidepressants in Remitted Depression

Role: collaborator

NCT07338708Not ApplicableCompleted

Visual Outcomes and Quality of Life After Vivity EDOF IOL Implantation in Early-Stage Keratoconus

Role: lead

NCT05735912Not ApplicableActive Not Recruiting

EUS-RFA Versus Surgery for Pancreatic Insulinoma (ERASIN-RCT)

Role: lead

NCT06406387Active Not Recruiting

ATRX/DAXX in EUS-FNB Specimens of Pan-NETs

Role: lead

NCT07207928Completed

Evaluation of Clinical Outcomes, Tolerability, and Costs of Avelumab Maintenance and Pembrolizumab Second-Line Therapy in Advanced Urothelial Cancer.

Role: lead

NCT07325877Not ApplicableNot Yet Recruiting

Supra-papillary Versus Trans-papillary Biliary Stenting in Malignant Peri-hilar Stenosis

Role: lead

NCT07262957Phase 4Recruiting

Preventing Postoperative Complications in Patients Undergoing High-risk Pancreatoduodenectomy With a Bundle Approach Including Hydrocortisone, Octreotide, and the Teres Ligament Patch (PANENCA)

Role: collaborator

NCT07295119Not ApplicableCompleted

Evaluation Of Patient Satisfaction And Quality Of Vision After EDOF Or Trifocal IOL Implantation

Role: lead

NCT07291609Recruiting

Microplastics and Nanoplastics in Patients With Chronic Coronary Syndromes

Role: collaborator

NCT07289035Phase 2Not Yet Recruiting

Early Study on Tamoxifen Safety/Tolerability in Cystic Fibrosis Patients Unable to Use CFTR Modulators.

Role: lead

NCT07258186Recruiting

Generation of Endometrial Carcinoma Organoids